StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Perspective Therapeutics's operating margin for the twelve months ending Jun 30, 2022 was -59.5%. For fiscal 2022 it was -59.5%, against -34.3% the year before. The highest annual figure on record is -34.3% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2022Jun 30, 2022-59.5%−25.2
FY2021Jun 30, 2021-34.3%+1.6
FY2020Jun 30, 2020-35.9%+35.9
FY2019Jun 30, 2019-71.8%+41.8
FY2018Jun 30, 2018-113.6%+18.9
FY2017Jun 30, 2017-132.5%−25.9
FY2016Jun 30, 2016-106.6%−12.4
FY2015Jun 30, 2015-94.2%+14.6
FY2014Jun 30, 2014-108.7%−18.9
FY2013Jun 30, 2013-89.9%−18.9
FY2012Jun 30, 2012-71.0%−14.4
FY2011Jun 30, 2011-56.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2022CQ2 2022Jun 30, 2022-84.1%−43.7
Q3 FY2022CQ1 2022Mar 31, 2022-47.3%−17.8
Q2 FY2022CQ4 2021Dec 31, 2021-58.1%−21.1
Q1 FY2022CQ3 2021Sep 30, 2021-88.7%−58.7
Q4 FY2021CQ2 2021Jun 30, 2021-40.3%+11.8
Q3 FY2021CQ1 2021Mar 31, 2021-29.5%−10.4
Q2 FY2021CQ4 2020Dec 31, 2020-37.0%+3.9
Q1 FY2021CQ3 2020Sep 30, 2020-29.9%+6.2
Q4 FY2020CQ2 2020Jun 30, 2020-52.2%+7.3
Q3 FY2020CQ1 2020Mar 31, 2020-19.0%+41.4
Q2 FY2020CQ4 2019Dec 31, 2019-40.9%+34.1
Q1 FY2020CQ3 2019Sep 30, 2019-36.1%+61.1
Q4 FY2019CQ2 2019Jun 30, 2019-59.5%+88.4
Q3 FY2019CQ1 2019Mar 31, 2019-60.4%+24.7
Q2 FY2019CQ4 2018Dec 31, 2018-75.1%+20.5
Q1 FY2019CQ3 2018Sep 30, 2018-97.2%+31.0
Q4 FY2018CQ2 2018Jun 30, 2018-147.8%−11.8
Q3 FY2018CQ1 2018Mar 31, 2018-85.1%+23.2
Q2 FY2018CQ4 2017Dec 31, 2017-95.6%+48.3
Q1 FY2018CQ3 2017Sep 30, 2017-128.2%+17.5
Q4 FY2017CQ2 2017Jun 30, 2017-136.1%−24.1
Q3 FY2017CQ1 2017Mar 31, 2017-108.3%+2.4
Q2 FY2017CQ4 2016Dec 31, 2016-143.9%−25.3
Q1 FY2017CQ3 2016Sep 30, 2016-145.7%−59.2
Q4 FY2016CQ2 2016Jun 30, 2016-112.0%−29.6
Q3 FY2016CQ1 2016Mar 31, 2016-110.8%−20.0
Q2 FY2016CQ4 2015Dec 31, 2015-118.6%–
Q1 FY2016CQ3 2015Sep 30, 2015-86.5%–
Q4 FY2015CQ2 2015Jun 30, 2015-82.4%–
Q3 FY2015CQ1 2015Mar 31, 2015-90.8%–

More Perspective Therapeutics figures

See a number that looks wrong?